Skip to main content

Evolv Technologies Holdings, Inc.

For the period ended Mar 31, 2025. Filed May 20, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 20, 2025

EVLV$4.44-6.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Cash Flows (Unaudited)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

Three Months EndedMarch 31,
20252024
(As Restated)
Cash flows from operating activities:
Net loss$(1,689)$(11,272)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization5,5303,457
Write-off of inventory and change in inventory reserve21,059
Loss on disposal of property and equipment321—
Stock-based compensation4,8796,430
Amortization of premium on marketable securities, net of change in accrued interest71200
Non-cash lease expense424354
Change in allowance for expected credit losses41(267)
Change in fair value of earn-out liability(8,976)(6,899)
Change in fair value of contingently issuable common stock(1,653)(527)
Change in fair value of public warrant liability(1,721)(2,151)
Changes in operating assets and liabilities
Accounts receivable(6,124)2,157
Inventory7,172(1,760)
Commission assets203(89)
Contract assets(321)280
Other assets82203
Prepaid expenses and other current assets(3,859)(3,738)
Accounts payable2,780(695)
Deferred revenue500(558)
Accrued expenses and other current liabilities(71)(1,943)
Operating lease liability(130)(392)
Net cash used in operating activities(2,539)(16,151)
Cash flows from investing activities:
Development of internal-use software(1,556)(1,567)
Purchases of property and equipment(12,730)(19,827)
Purchases of marketable securities(9,875)(14,567)
Proceeds from maturities of marketable securities14,80029,241
Net cash used in investing activities(9,361)(6,720)
Cash flows from financing activities:
Proceeds from exercise of stock options20302
Net cash provided by financing activities20302
Effect of exchange rate changes on cash and cash equivalents(46)3
Net decrease in cash, cash equivalents and restricted cash(11,926)(22,566)
Cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period37,01567,437
Cash, cash equivalents and restricted cash at end of period$25,089$44,871
Supplemental disclosure of non-cash activities
Transfer of property and equipment to inventory$564$468
Capital expenditures incurred but not yet paid3,09812,030
Capitalization of stock compensation247175
Operating lease liabilities arising from obtaining right-of-use assets—1,694
Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents$25,089$44,596
Restricted cash, noncurrent—275
Total cash, cash equivalents and restricted cash shown in the statements of cash flows$25,089$44,871
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.